Back to Search Start Over

In vivo and in vitro SAR of tetracyclic MAPKAP-K2 (MK2) inhibitors. Part I.

Authors :
Revesz L
Schlapbach A
Aichholz R
Feifel R
Hawtin S
Heng R
Hiestand P
Jahnke W
Koch G
Kroemer M
Möbitz H
Scheufler C
Velcicky J
Huppertz C
Source :
Bioorganic & medicinal chemistry letters [Bioorg Med Chem Lett] 2010 Aug 01; Vol. 20 (15), pp. 4715-8. Date of Electronic Publication: 2010 Apr 13.
Publication Year :
2010

Abstract

Pyrrolo[2,3-f]isoquinoline based amino acids, tetracyclic lactams and cyclic ketone analogues are described as novel MK2 inhibitors with IC(50) as low as 5nM and good selectivity profiles against a number of related kinases including ERK, p38alpha and JNKs. TNFalpha release was suppressed from human peripheral blood mononuclear cells (hPBMCs), and a representative compound inhibited LPS induced TNFalpha release in mice illustrating the potential of this series to provide orally active MK2 inhibitors.<br /> (Copyright 2010 Elsevier Ltd. All rights reserved.)

Details

Language :
English
ISSN :
1464-3405
Volume :
20
Issue :
15
Database :
MEDLINE
Journal :
Bioorganic & medicinal chemistry letters
Publication Type :
Academic Journal
Accession number :
20594847
Full Text :
https://doi.org/10.1016/j.bmcl.2010.04.024